Grove Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.9K | Buy |
1,009
+48
| +5% | +$3.75K | 0.01% | 369 |
|
|
2025
Q1 | $69.7K | Hold |
961
| – | – | 0.01% | 368 |
|
|
2024
Q4 | $71.1K | Buy |
961
+29
| +3% | +$2.15K | 0.01% | 331 |
|
|
2024
Q3 | $61.5K | Buy |
932
+82
| +10% | +$5.41K | 0.01% | 346 |
|
|
2024
Q2 | $78.5K | Sell |
850
-10
| -1% | -$924 | 0.01% | 303 |
|
|
2024
Q1 | $82.2K | Hold |
860
| – | – | 0.01% | 312 |
|
|
2023
Q4 | $65.6K | Hold |
860
| – | – | 0.01% | 326 |
|
|
2023
Q3 | $59.6K | Sell |
860
-71
| -8% | -$4.92K | 0.01% | 339 |
|
|
2023
Q2 | $87.8K | Sell |
931
-15
| -2% | -$1.42K | 0.02% | 305 |
|
|
2023
Q1 | $78.3K | Buy |
946
+53
| +6% | +$4.39K | 0.02% | 316 |
|
|
2022
Q4 | $67K | Buy |
+893
| New | +$67K | 0.01% | 334 |
|
|
2018
Q1 | – | Sell |
-510
| Closed | -$19K | – | 262 |
|
|
2017
Q4 | $19K | Hold |
510
| – | – | 0.01% | 391 |
|
|
2017
Q3 | $19K | Hold |
510
| – | – | 0.01% | 402 |
|
|
2017
Q2 | $20K | Buy |
510
+330
| +183% | +$12.9K | 0.01% | 377 |
|
|
2017
Q1 | $6K | Hold |
180
| – | – | ﹤0.01% | 393 |
|
|
2016
Q4 | $6K | Buy |
+180
| New | +$6K | ﹤0.01% | 430 |
|